Jorge Gavilondo

1.5k total citations
70 papers, 1.1k citations indexed

About

Jorge Gavilondo is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jorge Gavilondo has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 29 papers in Radiology, Nuclear Medicine and Imaging and 27 papers in Immunology. Recurrent topics in Jorge Gavilondo's work include Monoclonal and Polyclonal Antibodies Research (28 papers), Glycosylation and Glycoproteins Research (17 papers) and Immunotherapy and Immune Responses (10 papers). Jorge Gavilondo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), Glycosylation and Glycoproteins Research (17 papers) and Immunotherapy and Immune Responses (10 papers). Jorge Gavilondo collaborates with scholars based in Cuba, United States and Thailand. Jorge Gavilondo's co-authors include Marta Ayala, James W. Larrick, Boris Acevedo, Gertrudis Rojas, Mónica Béquet‐Romero, Yanelys Morera Díaz, M. Arias Rodríguez, Yasser Perera, Marta Dueñas and Merardo Pujol and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Trends in biotechnology.

In The Last Decade

Jorge Gavilondo

69 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Gavilondo Cuba 20 724 410 323 238 130 70 1.1k
Dianne M. Fishwild United States 18 586 0.8× 609 1.5× 676 2.1× 214 0.9× 227 1.7× 33 1.4k
Hennie R. Hoogenboom United Kingdom 8 1.5k 2.1× 1.8k 4.3× 490 1.5× 122 0.5× 177 1.4× 9 2.0k
Ryo Morishita Japan 17 1.2k 1.7× 178 0.4× 155 0.5× 127 0.5× 80 0.6× 39 1.6k
Marco Bestagno Italy 25 800 1.1× 481 1.2× 462 1.4× 92 0.4× 552 4.2× 51 1.9k
M.R. Suresh Canada 18 551 0.8× 500 1.2× 228 0.7× 74 0.3× 103 0.8× 44 981
Darius Ghaderi United States 12 899 1.2× 380 0.9× 284 0.9× 115 0.5× 77 0.6× 12 1.1k
Ricarda Finnern Germany 20 1.1k 1.5× 1.1k 2.6× 466 1.4× 320 1.3× 364 2.8× 30 1.8k
William J.J. Finlay United States 20 755 1.0× 515 1.3× 213 0.7× 183 0.8× 112 0.9× 28 1.2k
Roman M. Chicz United States 21 901 1.2× 528 1.3× 1.7k 5.3× 40 0.2× 155 1.2× 34 2.5k
Peter Jantscheff Germany 20 600 0.8× 183 0.4× 228 0.7× 70 0.3× 359 2.8× 40 1.3k

Countries citing papers authored by Jorge Gavilondo

Since Specialization
Citations

This map shows the geographic impact of Jorge Gavilondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Gavilondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Gavilondo more than expected).

Fields of papers citing papers by Jorge Gavilondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Gavilondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Gavilondo. The network helps show where Jorge Gavilondo may publish in the future.

Co-authorship network of co-authors of Jorge Gavilondo

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Gavilondo. A scholar is included among the top collaborators of Jorge Gavilondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Gavilondo. Jorge Gavilondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz, Yanelys Morera, Mónica Béquet‐Romero, Rafael Delgado-Martínez, et al.. (2023). Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in immunocompetent mouse tumor models. Cancer Letters. 561. 216156–216156. 3 indexed citations
2.
Díaz, Yanelys Morera, et al.. (2018). Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside. Seminars in Oncology. 45(1-2). 68–74. 6 indexed citations
3.
Díaz, Yanelys Morera, Mónica Béquet‐Romero, Ana de la Torre, et al.. (2017). Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine. Vaccine. 35(28). 3582–3590. 24 indexed citations
4.
5.
Gavilondo, Jorge, Amaury Pupo, Vivian Huerta, et al.. (2013). Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor. Molecular BioSystems. 9(8). 2097–2106. 20 indexed citations
6.
Béquet‐Romero, Mónica, et al.. (2012). CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors. Vaccine. 30(10). 1790–1799. 26 indexed citations
7.
Ávila, Matías A., et al.. (2011). Phase I Clinical Trial of the 131 I-Labeled Anticarcinoembryonic Antigen CIGB-M3 Multivalent Antibody Fragment. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 353–363. 7 indexed citations
8.
Valdés, Rodolfo, et al.. (2005). Production of an anti-HBsAg mouse IgG-2bk monoclonal antibody in hollow fiber bioreactors using different cell culture media and operation modes. Biotecnología aplicada. 22(2). 112–116. 1 indexed citations
9.
Rojas, Gertrudis, et al.. (2005). Efficient construction of a highly useful phage-displayed human antibody repertoire. Biochemical and Biophysical Research Communications. 336(4). 1207–1213. 11 indexed citations
10.
Rodríguez, M. Arias, et al.. (2003). Transient expression of a full-size antibody against Hepatitis B surface antigen in plant cell suspension cultures. Biotecnología aplicada. 20(3). 152–154. 1 indexed citations
11.
Acevedo, Boris, et al.. (2002). Purification of the recombinant hepatitis B core antigen, and its potential use for the diagnosis of hepatitis B virus infection. Biotecnología aplicada. 19. 138–142. 5 indexed citations
12.
Freyre, Freya, et al.. (2001). Hexa-histidine tag as a novel alternative for one-step direct labelling of a single-chain Fv antibody fragment with 99mTc. Nuclear Medicine Communications. 22(10). 1089–1094. 8 indexed citations
13.
14.
Gavilondo, Jorge, et al.. (1998). A recombinant protein based immunoassay for the combined detection of antibodies to HIV-1, HIV-2 and HTLV-I. Journal of Virological Methods. 70(1). 85–91. 3 indexed citations
15.
Musacchio, Alexis, et al.. (1998). Mouse monoclonal antibodies against outer membrane proteins of a vaccine strain of Neisseria meningitidis B: 4:P1.15. Lund University Publications (Lund University). 10(2). 65–70. 1 indexed citations
16.
Duarte, Carlos A., Jorma Hinkula, Per-Anders Broliden, et al.. (1991). Monoclonal Antibodies to Conserved Regions of the Major Core Protein ( gag 24) of HIV-1 and HIV-2. AIDS Research and Human Retroviruses. 7(1). 97–101. 10 indexed citations
17.
Duarte, Carlos A., et al.. (1990). Radio and enzyme immunoassays for human epidermal growth factor with mouse monoclonal antibodies. Biotecnología aplicada. 7(1). 42–51. 1 indexed citations
18.
García, Carlos, et al.. (1990). Tropical treatment of cutaneous T-cell lymphoma skin lesions with the mouse anti-CD6 monoclonal antibody IOR-T1. Biotecnología aplicada. 7(2). 176–181. 2 indexed citations
19.
Gavilondo, Jorge, et al.. (1982). Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.. PubMed. 29(1). 73–9. 4 indexed citations
20.
Marinello, Michelle J., et al.. (1975). In vitro incorporation of tritiated thymidine by the Sternberg-Reed cells in Hodgkin disease.. PubMed. 22(2). 185–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianne M. Fishwild Breakdown of academic impact, for papers by Hennie R. Hoogenboom Breakdown of academic impact, for papers by Ryo Morishita Breakdown of academic impact, for papers by Marco Bestagno Breakdown of academic impact, for papers by M.R. Suresh Breakdown of academic impact, for papers by Darius Ghaderi Breakdown of academic impact, for papers by Ricarda Finnern Breakdown of academic impact, for papers by William J.J. Finlay Breakdown of academic impact, for papers by Roman M. Chicz Breakdown of academic impact, for papers by Peter Jantscheff
Rankless by CCL
2026